Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

Active

GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED having CIN U24231MH1994PTC079977 is 30 years , 9 month & 3 days old Private Indian Company incorporated on 01 Aug 1994. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 3,000,000 and its paid up capital is Rs. 2,410,200. It's NIC code is 24231 (which is part of its CIN).

As per the NIC code, it is inolved in Manufacture Of Chemical Substances Used In The Manufacture Of Pharmaceuticals: Antibiotics . GENOME PHARMACEUTICALS AND CHEMICALS Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2023. Directors of GENOME PHARMACEUTICALS AND CHEMICALS are Mahendra Kumar Kumawat and Madhusudan Govindprasad Ruia.

GENOME PHARMACEUTICALS AND CHEMICALS ' Corporate Identification Number (CIN) is U24231MH1994PTC079977 and its registration number is 079977. Users may contact GENOME PHARMACEUTICALS AND CHEMICALS on its Email address - finance@agio-pharma.com Registered address of GENOME PHARMACEUTICALS AND CHEMICALS is A-39 NANDJYOT INDUSTRIALESATATE KURLA ANDHERI RD SAFED POOL,MUMBAI,Maharashtra,India-400072. Current status of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED is - Active.

Key Indicators

Authorised Capital
3,000,000

as on 08/01/1994

Paid Up Capital
2,410,200

as on 08/01/1994

Company Age
30 Year, 9 Months
Last Filing with ROC
1 Year, 7 Months

Company Information

CIN U24231MH1994PTC079977
Company Status Active
Registration Number 079977
Date of Incorporation 08/01/1994
RoC ROC Mumbai
Company Age 30 years & 284 days
Authorized Capital ₹ 3000000
Paid-up capital ₹ 2410200
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity Computer programming, consultancy and related activities
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID finance@agio-pharma.com
Address A-39 NANDJYOT INDUSTRIALESATATE KURLA ANDHERI RD SAFED POOL MUMBAI Maharashtra India 400072
Website agio-pharma.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director 02/06/2004 00018971 *****6008D 20 years
Director 11/30/2021 08873555 *****7065K 1 years
Director 04/20/2023 00018971 *****6008D 0 years

Companies connected through Directors

Name Status CIN Common Directors Address

Charges on assets

1

SBICAP TRUSTEE COMPANY LIMITED

No. of Loans: 1

Total Amount: 656,900,000.00 cr

2

Others

No. of Loans: 4

Total Amount: 814,600,000.00 cr

3

STATE BANK OF INDIA

No. of Loans: 1

Total Amount: 553,500,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
SBICAP TRUSTEE COMPANY LIMITED Churchgate, Mumbai 656,900,000 24 Jul, 2024 - - Open
Others 66/80, MUMBAI SAMACHAR MARG, FORT, 30,800,000 06 Apr, 2022 - 10 May, 2024 Closed
Others Ranade Rd. & Gokhale Rd. Junction,Dadar(W) 367,000,000 23 Mar, 2011 08 Nov, 2019 - Open
Others Mumbai Samachar Marg, Fort 360,000,000 25 Jul, 2012 23 Jun, 2021 17 May, 2024 Closed
Others Mumbai Samachar Marg, Fort 56,800,000 23 Jun, 2021 - 10 May, 2024 Closed
STATE BANK OF INDIA R T O LANE, ANDHERI (W) 553,500,000 30 Nov, 2002 16 Oct, 2008 29 Feb, 2012 Closed

Registered Details

CIN
U24231MH1994PTC079977
PAN
U24231MH1994PTC079977
Incorporation
30 years , 9 month
Company Email
finance@agio-pharma.com
Paid up Capital
₹ 2,410,200
Authorised Capital
₹ 3,000,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Manufacture Of Chemical Substances Used In The Manufacture Of Pharmaceuticals: Antibiotics

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

unlock

Subscribe to access detailed insight of companies

subscribe
Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4
unlock

Subscribe to access detailed insight of companies

subscribe
unlock

Subscribe to access detailed insight of companies

subscribe

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales lock lock lock lock lock
Operating profit lock lock lock lock lock
Net profit lock lock lock lock lock
Gross margin lock lock lock lock lock
Operating margin lock lock lock lock lock
Net margin lock lock lock lock lock
Networth lock lock lock lock lock
Borrowings lock lock lock lock lock
Assets lock lock lock lock lock
Debt to equity lock lock lock lock lock
Current ratio lock lock lock lock lock
ROE lock lock lock lock lock
Days payable lock lock lock lock lock
WC days lock lock lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

unlock

Subscribe to access detailed insight of companies

subscribe
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0.00 0.00 0.00 0.00 0.00
Reserves 0.00 0.00 0.00 0.00 0.00
Borrowings + 0.00 0.00 0.00 0.00 0.00
Long term borrowings 0.00 0.00 0.00 0.00 0.00
Short term borrowings 0.00 0.00 0.00 0.00 0.00
Trade payables + 0.00 0.00 0.00 0.00 0.00
Days payable 0.00 0.00 0.00 0.00 0.00
Other liabilities + 0.00 0.00 0.00 0.00 0.00
Other non-current liabilities 0.00 0.00 0.00 0.00 0.00
Other current liabilities 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.00 0.00 0.00 0.00 0.00
Fixed Assets + 0.00 0.00 0.00 0.00 0.00
Tangible assets 0.00 0.00 0.00 0.00 0.00
CWIP 0.00 0.00 0.00 0.00 0.00
Intangible assets 0.00 0.00 0.00 0.00 0.00
LT loans and advances 0.00 0.00 0.00 0.00 0.00
Other non-current assets 0.00 0.00 0.00 0.00 0.00
Current assets + 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00
Trade receivables 0.00 0.00 0.00 0.00 0.00
Cash and cash equivalents 0.00 0.00 0.00 0.00 0.00
ST loans and advances 0.00 0.00 0.00 0.00 0.00
Other current assets 0.00 0.00 0.00 0.00 0.00
Total assets 0.00 0.00 0.00 0.00 0.00
unlock

Subscribe to access detailed insight of companies

subscribe
<
Percentage of assets Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 44 78 90 45 38
Reserves 44 78 90 45 38
Borrowings + 44 78 90 45 38
Long term borrowings 44 78 90 45 38
Short term borrowings 44 78 90 45 38
Trade payables + 44 78 90 45 38
Days payable 44 78 90 45 38
Other liabilities + 44 78 90 45 38
Other non-current liabilities 44 78 90 45 38
Other current liabilities 44 78 90 45 38
Total liabilities 44 78 90 45 38
Fixed Assets + 44 78 90 45 38
Tangible assets 44 78 90 45 38
CWIP44 78 90 45 38
Intangible assets 44 78 90 45 38
LT loans and advances 44 78 90 45 38
Other non-current assets 44 78 90 45 38
Current assets + 44 78 90 45 38
Inventories 44 78 90 45 38
Trade receivables 44 78 90 45 38
Cash and cash equivalents 44 78 90 45 38
ST loans and advances 44 78 90 45 38
Other current assets 44 78 90 45 38
Total assets 44 78 90 45 38
unlock

Subscribe to access detailed insight of companies

subscribe

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales + lock lock lock lock lock
Sales growth % lock lock lock lock lock
Expenses + lock lock lock lock lock
Cost of goods lock lock lock lock lock
Employee cost lock lock lock lock lock
Other costs lock lock lock lock lock
Operating profit + lock lock lock lock lock
Operating margin % lock lock lock lock lock
Other income lock lock lock lock lock
Interest lock lock lock lock lock
Depreciation lock lock lock lock lock
Exceptional items lock lock lock lock lock
Profit before tax lock lock lock lock lock
Tax lock lock lock lock lock
Profit - disc. ops lock lock lock lock lock
Net profit lock lock lock lock lock
Net margin % lock lock lock lock lock
Precentage of total income Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales + lock lock lock lock lock
Sales growth % lock lock lock lock lock
Expenses + lock lock lock lock lock
Cost of goods lock lock lock lock lock
Employee cost lock lock lock lock lock
Other costs lock lock lock lock lock
Operating profit + lock lock lock lock lock
Operating margin % lock lock lock lock lock
Other income lock lock lock lock lock
Interest lock lock lock lock lock
Depreciation lock lock lock lock lock
Exceptional items lock lock lock lock lock
Profit before tax lock lock lock lock lock
Tax lock lock lock lock lock
Profit - disc. ops lock lock lock lock lock
Net profit lock lock lock lock lock
Net margin % lock lock lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Solvency + lock lock lock lock lock
Total Debt/Equity lock lock lock lock lock
Net Debt/Equity lock lock lock lock lock
Total Debt/Assets lock lock lock lock lock
Total Assets/Equity lock lock lock lock lock
Liquidity + lock lock lock lock lock
Current Ratio lock lock lock lock lock
Quick Ratio lock lock lock lock lock
Interest Coverage lock lock lock lock lock
Performance lock lock lock lock lock
Gross Margin lock lock lock lock lock
Operating Margin lock lock lock lock lock
Net Margin lock lock lock lock lock
Return + lock lock lock lock lock
Return on Equity lock lock lock lock lock
Pre-tax ROCE lock lock lock lock lock
Return on Assets lock lock lock lock lock
Pre-tax ROIC lock lock lock lock lock
Efficiency + lock lock lock lock lock
Days Payable lock lock lock lock lock
Days Inventory lock lock lock lock lock
Days Receivable lock lock lock lock lock
Fixed Asset Turnover lock lock lock lock lock
Total Asset Turnover lock lock lock lock lock
Working Capital lock lock lock lock lock
Cash Conversion Cycle lock lock lock lock lock
Working Capital Days lock lock lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

What is GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED ?

GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED having CIN U24231MH1994PTC079977 is 30 years , 9 month old Private Indian Company incorporated with MCA on 01 Aug 1994. GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 3,000,000 and paid-up capital is 2,410,200.

What is the CIN of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED?

CIN of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED is U24231MH1994PTC079977.

Where is GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED located?

Address of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED is A-39 nandjyot industrialesatate kurla andheri rd safed pool,mumbai,maharashtra,india-400072,.

Who are the directors of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED ?

The company has 3 directors/key management personnel MADHUSUDAN RUIA,MAHENDRA KUMAWAT,MADHUSUDAN RUIA,

What is the contact details of GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED ?

Email : finance@agio-pharma.com
Address : A-39 NANDJYOT INDUSTRIALESATATE KURLA ANDHERI RD SAFED POOL MUMBAI Maharashtra India 400072

What does GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED do?

GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Search

Enquiry